“The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory distress syndrome coronavirus 2 (SARS-Cov-2), was identified for the first time in late 2019 in China, resulting in a global pandemic of massive impact. Despite a fast development and implementation of vaccination strategies, and the scouting of several pharmacological treatments, alternative effective treatments are still needed. In this regard, cannabinoids represent a promising approach because they have been proven to exhibit several immunomodulatory, anti-inflammatory, and antiviral properties in COVID-19 disease models and related pathological conditions. This mini-review aims at providing a practical brief overview of the potential applications of cannabinoids so far identified for the treatment and prevention of COVID-19, finally considering key aspects related to their technological and clinical implementation.”
https://pubmed.ncbi.nlm.nih.gov/35512732/
“Overall, cannabinoids offer a great pharmacological potential in the management of COVID-19. It is to be hoped that the scientific evidence so far reported on cannabinoids effects along with the possibilities offered by drug delivery systems will entice the development of valuable therapies in this area.”